Responses to pure antiestrogens (ICI 164384, ICI 182780) in estrogen-sensitive and -resistant experimental and clinical breast cancer.
Nicholson
R I
RI
Tenovus Cancer Research Centre, University of Wales College of Medicine, Heath Park, United Kingdom.
Gee
J M
JM
Manning
D L
DL
Wakeling
A E
AE
Montano
M M
MM
Katzenellenbogen
B S
BS
D001943:Breast Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D004351:Drug Resistance; D004958:Estradiol / Q000031:analogs & derivatives* / Q000494:pharmacology; D045166:Estradiol Congeners / Q000494:pharmacology; D004965:Estrogen Antagonists / Q000494:pharmacology*; D005260:Female; D000077267:Fulvestrant; D006801:Humans; D066298:In Vitro Techniques; D053284:Polyunsaturated Alkamides; D011960:Receptors, Estrogen / Q000378:metabolism; D013629:Tamoxifen / Q000494:pharmacology; D014407:Tumor Cells, Cultured
D045166:Estradiol Congeners; D004965:Estrogen Antagonists; D053284:Polyunsaturated Alkamides; D011960:Receptors, Estrogen; D013629:Tamoxifen; D000077267:Fulvestrant; D004958:Estradiol; C051781:ICI 164384